A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
Clinical trial NCT05800366 · RECRUITING
Trial details
- NCT number
- NCT05800366
- Sponsor
- Jennifer Crombie, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2026-09-15
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.